Revenue for DexCom (DXCM)
According to DexCom's latest reported financial statements, the company's current revenue (TTM) is $4.66B USD. Revenue is the total income from selling goods or services before any expenses. Unlike net income (earnings), revenue does not subtract operating costs, taxes, or other charges. Figures are in USD; chart and tables below use historical filings (not a live revenue-per-second estimate).
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
DXCM
Currently viewingRevenueSwitch metric
TTM (last 4 quarters)
$4.66B
YoY change
+15.6%
5Y CAGR
+19.3%
Peak year (2025)
$4.66B
Cumulative revenue
$24.49B
Revenue history chart for DexCom (DXCM) from 2000 to 2025
Revenue history table for DexCom (DXCM) from 2000 to 2025
| Fiscal year | Period ended | Reported | Revenue | YoY |
|---|---|---|---|---|
| 2025 | $4.66B | +15.6% | ||
| 2024 | $4.03B | +11.3% | ||
| 2023 | $3.62B | +24.5% | ||
| 2022 | $2.91B | +18.8% | ||
| 2021 | $2.45B | +27.1% | ||
| 2020 | $1.93B | +30.5% | ||
| 2019 | $1.48B | +43.1% | ||
| 2018 | $1.03B | +43.6% | ||
| 2017 | $718.50M | +25.3% | ||
| 2016 | $573.30M | +42.6% | ||
| 2015 | $402.00M | +55.1% | ||
| 2014 | $259.20M | +62.0% | ||
| 2013 | $160.00M | +60.2% | ||
| 2012 | $99.90M | +31.0% | ||
| 2011 | $76.27M | +56.8% | ||
| 2010 | $48.63M | +63.8% | ||
| 2009 | $29.69M | +201.8% | ||
| 2008 | $9.84M | +112.6% | ||
| 2007 | $4.63M | +113.2% | ||
| 2006 | $2.17M | — | ||
| 2005 | $0 | — | ||
| 2004 | $0 | — | ||
| 2003 | $0 | — | ||
| 2002 | $0 | — | ||
| 2001 | $0 | — | ||
| 2000 | $0 | — |
Revenue values are taken from DexCom's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
As of the 2025 fiscal year, DexCom (DXCM) reported revenue of $4.66B – grew 15.6% year-over-year.
Over 2020–2025 (5 years), DexCom revenue expanded at a +19.3% compound annual rate, sustaining 20 straight years of year-over-year growth.
The dataset's maximum revenue sits at $4.66B (2025); the minimum reading of $0 dates to 2000.
DexCom (DXCM) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $65.09B.
DexCom Revenue by Year
DexCom Revenue 2025: $4.66B
DexCom revenue in 2025 was $4.66B, grew 15.6% from 2024. This figure represents the highest annual value in the available history.
DexCom Revenue 2024: $4.03B
DexCom revenue in 2024 was $4.03B, grew 11.3% from 2023.
DexCom Revenue 2023: $3.62B
DexCom revenue in 2023 was $3.62B, grew 24.5% from 2022.
DexCom Revenue 2022: $2.91B
DexCom revenue in 2022 was $2.91B, grew 18.8% from 2021.
DexCom Revenue 2021: $2.45B
DexCom revenue in 2021 was $2.45B.
See more financial history for DexCom (DXCM).
Sector peers — Revenue
Companies in the same sector as DexCom, ranked by their latest revenue.
| Company | Revenue | Sector |
|---|---|---|
| UnitedHealth Group Incorporated (UNH) | $447.57B | Healthcare |
| Novo Nordisk A/S (NVO) | $309.06B | Healthcare |
| Johnson & Johnson (JNJ) | $94.19B | Healthcare |
| Eli Lilly and Company (LLY) | $65.18B | Healthcare |
| Merck & Co., Inc. (MRK) | $65.01B | Healthcare |
| AbbVie Inc. (ABBV) | $61.16B | Healthcare |
| AstraZeneca PLC (AZN) | $58.74B | Healthcare |
| Amgen Inc. (AMGN) | $36.74B | Healthcare |
Frequently asked questions
What is DexCom's revenue?
- Latest reported revenue for DexCom (DXCM) is $4.66B (period ending December 31, 2025).
How has DexCom revenue changed year-over-year?
- DexCom (DXCM) revenue changed +15.6% year-over-year on the latest annual filing.
What is the long-term growth rate of DexCom revenue?
- DexCom (DXCM) revenue compound annual growth rate is +19.3% over the most recent 5 years available.
When did DexCom revenue hit its highest annual value?
- DexCom revenue reached its highest annual value of $4.66B in 2025.
What was DexCom revenue in 2024?
- DexCom (DXCM) revenue in 2024 was $4.03B.
What was DexCom revenue in 2025?
- DexCom (DXCM) revenue in 2025 was $4.66B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
DXCM Overview
Company profile, financial tools, and key metrics
DXCM Revenue Counter
Earns $147.83 every second. See per minute, hour, and day.
DXCM Earnings Counter
Earns $26.52 per second net profit. See per minute, hour, and day.
DXCM Economic Scale
Exceeds Suriname's GDP. Compare with world economies.
DXCM What If Invested
What if you had invested $1,000? See historical returns from any date.
DXCM How It Makes Money
Discover visual breakdown of $4.66B in revenue — where it comes from and where it goes.
DXCM Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
DXCM Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
DXCM Daily Price Character
Explosive · 49.4% historical win rate (green days). Streaks & record days.
DXCM Buybacks
1.95% TTM buyback yield. Shareholder yield & SBC comparison.
DXCM Stock Split History
1 split on record. Dates, ratios, and cumulative multiple.